Palatin Technologies, Inc. (PTN)
NASDAQ: PTN · Real-Time Price · USD
6.26
+0.13 (2.12%)
Nov 17, 2026, 9:37 AM EST - Market open
Palatin Technologies Employees
Palatin Technologies had 25 employees as of June 30, 2026. The number of employees decreased by 4 or 13.79% compared to the previous year.
Employees
25
Change (1Y)
-4
Growth (1Y)
-13.79%
Revenue / Employee
$527,401
Profits / Employee
-$335,116
Market Cap
11.08M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 25 | -4 | -13.79% |
| Jun 30, 2025 | 29 | -1 | -3.33% |
| Jun 30, 2024 | 30 | -4 | -11.76% |
| Jun 30, 2023 | 34 | 1 | 3.03% |
| Jun 30, 2022 | 33 | 7 | 26.92% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| CytoMed Therapeutics | 42 |
| Bolt Biotherapeutics | 23 |
| Lisata Therapeutics | 21 |
| Radiopharm Theranostics | 14 |
| Cellectar Biosciences | 11 |
| Purple Biotech | 10 |
| Intensity Therapeutics | 7 |
PTN News
- Just now - Palatin Technologies Quarterly report: Q1 2027 - Filings
- Just now - Palatin Technologies Earnings release: Q1 2027 - Filings
- 2 hours ago - Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update - PRNewsWire
- 1 day ago - Palatin’s peptide agonists show weight reduction efficacy in presentation - TheFly
- 1 day ago - Palatin’s peptide agonists show weight reduction efficacy in presentation - TheFly
- 1 day ago - Palatin Technologies Presents Compelling Preclinical Data on Next-Generation MC4R-Selective Peptide Agonists at ObesityWeek® 2026 - PRNewsWire
- 3 days ago - Palatin Technologies Slides: Corporate presentation - Filings
- 4 days ago - Palatin to Report First Quarter Fiscal Year 2027 Results - PRNewsWire